Biofrontera Inc.

BFRI | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.16

-$0.16 (-12.12%)

At close: Sep 21, 2026, 4:00 PM ET

$1.20

+$0.04 (+3.45%)

After-hours: Sep 21, 2026, 7:57 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-12.12%

(1D)

Rating

Updated: Aug 27, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $14.85M

1D Range

1.15 1.25

52W Range

0.56 1.66

Valuation (TTM)

PE -2

PB 2.49

EV/EBITDA -3.18

Valuation (NTM)

Forward PE 7.25

Forward PEG 0.01

Price Target $3

Cash Flow

FCF Yield -53.4%

SBC Adj. FCF Yield -61.0%

SBC Impact -14.2%

Margins

Gross Margin 84.5%

Operating Margin -9.4%

FCF Margin -17.2%

Growth (CAGR)

Revenue 3Y | 5Y 16.7% | 15.5%

Dil EPS 3Y | 5Y 89.0% | 77.5%

FCF 3Y | 5Y 45.6% | 29.0%

Returns

ROA -26.4%

ROE -127.8%

ROIC -31.2%

Financial Health

Net Cash

$47K

Current Ratio 1.18

Interest Coverage -18.81

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-Rho...

Sector Healthcare

Industry Medical - Pharmaceuticals

Employees 89

IPO Date Oct 28, 2021

Website www.biofrontera-us.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 11, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

Upside

+158.62%

Buy (0)

Hold (0)

Sell (0)

Analyst Details ➞